US-based StemCures will set up a manufacturing lab in Hyderabad, Telangana focused on stem cell therapy to create the largest stem cell manufacturing plant in India. The announcement was made after StemCures founder Dr. Sairam Atluri met with Telangana IT and Industries Minister K T Rama Rao in Boston, United States.
The facility will be put up with an investment of around USD 54 million and generate employment for around 150 people in two phases. It will leverage the latest technology and expertise from the US to manufacture affordable stem cell products for treating various medical conditions.
The Minister said that stem cell therapy is a promising new treatment and the lab will offer high-quality care, while making it more accessible to patients in India.
Currently, StemCures is completing research and development of the stem cell line at Aspire Bionest at the University of Hyderabad, and is ready to commence the first phase of the manufacturing lab project.
StemCures is an FDA-compliant medical clinic in Ohio, USA which specialises in stem cell therapy.
